Sang‐Cheol Lee

2.2k total citations · 1 hit paper
77 papers, 1.5k citations indexed

About

Sang‐Cheol Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sang‐Cheol Lee has authored 77 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 14 papers in Surgery. Recurrent topics in Sang‐Cheol Lee's work include Pancreatic and Hepatic Oncology Research (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Sang‐Cheol Lee is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Sang‐Cheol Lee collaborates with scholars based in South Korea, United States and South Africa. Sang‐Cheol Lee's co-authors include Se Hoon Park, Won Ki Kang, Ho Yeong Lim, Joon Oh Park, Jeeyun Lee, Young Suk Park, Jung Hun Kang, In Gyu Hwang, Keon Woo Park and Sung Yong Oh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sang‐Cheol Lee

73 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

2012 474 citations Jung Hun Kang, Soon Il Lee et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sang‐Cheol Lee South Korea	18	858	597	545	235	187	77	1.5k
Tomoyuki Matsunaga Japan	23	644 0.8×	757 1.3×	638 1.2×	208 0.9×	212 1.1×	137	1.7k
George Chalkiadakis Greece	24	919 1.1×	418 0.7×	941 1.7×	81 0.3×	160 0.9×	105	2.0k
Jianchun Yu China	23	800 0.9×	495 0.8×	565 1.0×	249 1.1×	448 2.4×	103	1.9k
Rajiv Kumar India	17	267 0.3×	340 0.6×	255 0.5×	81 0.3×	253 1.4×	75	1.1k
Savio George Barreto Australia	28	970 1.1×	1.6k 2.6×	1.7k 3.1×	180 0.8×	193 1.0×	155	2.6k
Maheswari Senthil United States	22	320 0.4×	400 0.7×	416 0.8×	251 1.1×	266 1.4×	92	1.3k
Raffaele De Luca Italy	20	421 0.5×	570 1.0×	527 1.0×	232 1.0×	251 1.3×	61	1.7k
Hiroyuki Konno Japan	27	799 0.9×	955 1.6×	1.5k 2.8×	95 0.4×	186 1.0×	104	2.3k
Keisuke Koeda Japan	24	1.5k 1.7×	470 0.8×	1.1k 2.1×	149 0.6×	281 1.5×	86	2.3k
Ralf Segersvärd Sweden	28	555 0.6×	1.4k 2.4×	1.1k 2.1×	252 1.1×	216 1.2×	69	2.0k

Countries citing papers authored by Sang‐Cheol Lee

Since Specialization

Citations

This map shows the geographic impact of Sang‐Cheol Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Cheol Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Cheol Lee more than expected).

Fields of papers citing papers by Sang‐Cheol Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Cheol Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Cheol Lee. The network helps show where Sang‐Cheol Lee may publish in the future.

Co-authorship network of co-authors of Sang‐Cheol Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Cheol Lee. A scholar is included among the top collaborators of Sang‐Cheol Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Cheol Lee. Sang‐Cheol Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Sang‐Won, Daeyoung Kim, Sung‐Hee Shin, et al.. (2024). Use of artificial intelligence-powered ECG to differentiate between cardiac and pulmonary pathologies in patients with acute dyspnoea in the emergency department. Open Heart. 11(2). e002924–e002924. 1 indexed citations

Lim, Seung Taek, Hye Ryun Kim, Eun Joo Kang, et al.. (2024). Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study. Oral Oncology. 151. 106739–106739. 2 indexed citations

Byeon, Hyung Kwon, Jae-Hong Park, Sang‐Cheol Lee, et al.. (2023). Effect of a Novel Handheld Photobiomodulation Therapy Device in the Management of Chemoradiation Therapy-Induced Oral Mucositis in Head and Neck Cancer Patients: A Case Series Study. Photonics. 10(3). 241–241. 4 indexed citations

Go, Se‐Il, Sang‐Cheol Lee, Woo Kyun Bae, et al.. (2021). Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). European Journal of Cancer. 157. 21–30. 17 indexed citations

Lim, Sung Hee, Jina Yun, Min-Young Lee, et al.. (2021). Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial. Yonsei Medical Journal. 62(8). 671–671. 7 indexed citations

Oh, Jong Jin, Seong Jin Jeong, Sung Il Hwang, et al.. (2018). Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases. Surgical Infections. 19(7). 704–710. 2 indexed citations

Kang, Minyong, Jong Jin Oh, Sang‐Cheol Lee, et al.. (2016). Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis. Clinical Genitourinary Cancer. 14(4). e363–e369. 3 indexed citations

Jo, Jung Ki, Jong Jin Oh, Sang‐Cheol Lee, et al.. (2016). Can robot-assisted laparoscopic radical prostatectomy (RALP) be performed very soon after biopsy?. World Journal of Urology. 35(4). 605–612. 6 indexed citations

Bae, Sang Byung, Nam-Su Lee, Kyu-Taek Lee, et al.. (2015). Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis. Cancer Research and Treatment. 48(2). 843–847. 23 indexed citations

10.

Lee, Sang‐Cheol, Sang Wook Lee, Myong Kim, et al.. (2015). Urodynamic assessment of bladder and urethral function among men with lower urinary tract symptoms after radical prostatectomy: A comparison between men with and without urinary incontinence. Korean journal of urology. 56(12). 803–803. 12 indexed citations

11.

Lee, Won Ki, Sung Kyu Hong, Sang‐Cheol Lee, et al.. (2015). Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis. Clinical Genitourinary Cancer. 13(5). 461–468. 20 indexed citations

12.

Park, Yong Hyun, Jin‐Woo Jung, Byung Ki Lee, et al.. (2014). Targeted therapy after complete resection of metastatic lesions in metastatic renal cell carcinoma. International Journal of Urology. 22(2). 153–157. 11 indexed citations

13.

Kim, Kyoung Ha, Se Hyung Kim, Jin A Yoon, et al.. (2014). Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell. Blood. 124(21). 5786–5786. 2 indexed citations

14.

Hong, Jung Yong, Eun Mi Nam, Jeeyun Lee, et al.. (2013). Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients. Cancer Chemotherapy and Pharmacology. 73(1). 125–130. 100 indexed citations

15.

Kim, Ji Yoon, et al.. (2012). Monosomy 22 Mosaicism Associated Thrombocytopenia Presenting as Behcet’s Disease. 19(1). 40–43. 2 indexed citations

16.

Lee, Seung-Min, et al.. (2012). Effects of kimchi supplementation on blood pressure and cardiac hypertrophy with varying sodium content in spontaneously hypertensive rats. Nutrition Research and Practice. 6(4). 315–315. 11 indexed citations

17.

Kang, Jung Hun, Soon Il Lee, Do Hyoung Lim, et al.. (2012). Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone. Journal of Clinical Oncology. 30(13). 1513–1518. 474 indexed citations breakdown →

18.

Kim, Han Jo, Young‐Woo Jeon, Jina Yun, et al.. (2011). Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer. Cancer Research and Treatment. 43(3). 154–159. 10 indexed citations

19.

Kim, Han Jo, Kyoung Ha Kim, Jina Yun, et al.. (2011). Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment. 43(1). 19–23. 12 indexed citations

20.

Kim, Hyun‐Jung, Sang‐Cheol Lee, Chan Kyu Kim, et al.. (2008). High Dose Chemotherapy and Autologous Peripheral Blood Stem CellTransplantation in Patients with Multiple Myeloma. 14(2). 99–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact